$Medtecs Intl (546.SG)$$Top Glove (BVA.SG)$$Riverstone (AP4....

According to the Futubull Financial News APP, the US Food and Drug Administration (FDA) is preparing to approve an updated version of the Covid vaccine targeted at the current epidemic virus strain as early as this week to deal with the largest summer epidemic in the United States in nearly two years. It is reported that the FDA will approve the updated mRNA vaccine targeting the KP.2 virus strain developed by Pfizer (PFE.US)/BioNTech (BNTX.US) and Moderna (MRNA.US). It is not yet known whether Novavax (NVAX.US) will also receive regulatory approval for its protein-based vaccine, which is currently under FDA review.